Fennec Pharmaceuticals Inc.FENCNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank13
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-10.89%
↑ 93% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-153.04%
Historical baseline
PeriodValueYoY Change
TTM-10.89%-207.9%
202410.09%+117.3%
2023-58.18%+96.0%
2022-1471.47%-
20210.00%-
20200.00%-
20190.00%-
20180.00%-
20170.00%-
20160.00%-